Early Use of Biologics Reduces Healthcare Costs in Crohn's Disease: Results from a United States Population-Based Cohort.

Ungaro, Ryan C; Naegeli, April N; Choong, Casey Kar-Chan; Shan, Mingyang; Zheng, Xianming Steve; Hunter Gibble, Theresa; Oneacre, Kathy; Colombel, Jean-Frederic

Ungaro, Ryan C; Naegeli, April N; Choong, Casey Kar-Chan; Shan, Mingyang; Zheng, Xianming Steve; Hunter Gibble, Theresa; Oneacre, Kathy; Colombel, Jean-Frederic.

Affiliation

Ungaro RC; The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. Ryan.ungaro@mssm.edu.
Naegeli AN; Eli Lilly and Company, Indianapolis, IN, USA.
Choong CK; Eli Lilly and Company, Indianapolis, IN, USA.
Shan M; Eli Lilly and Company, Indianapolis, IN, USA.
Zheng XS; Eli Lilly and Company, Indianapolis, IN, USA.
Hunter Gibble T; Eli Lilly and Company, Indianapolis, IN, USA.
Oneacre K; Syneos Health, Morrisville, NC, USA.
Colombel JF; Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Dig Dis Sci ; 69(1): 45-55, 2024 Jan.

Article de En | MEDLINE | ID: mdl-36920668

Sujet(s)
Mots clés

Crohn disease; Early intervention; Propensity score; Top-down treatment; Treatment outcomes

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Produits biologiques / Maladie de Crohn Type d'étude: Health_economic_evaluation / Prognostic_studies Limites: Adult / Humans Pays/Région comme sujet: America do norte Langue: En Journal: Dig Dis Sci Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google